IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 63.511
EU - Europa 36.233
AS - Asia 28.221
SA - Sud America 8.024
AF - Africa 663
Continente sconosciuto - Info sul continente non disponibili 156
OC - Oceania 58
Totale 136.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.446
SG - Singapore 11.742
RU - Federazione Russa 10.900
GB - Regno Unito 8.154
CN - Cina 7.004
BR - Brasile 6.541
IT - Italia 5.214
VN - Vietnam 4.110
DE - Germania 2.785
UA - Ucraina 2.599
CA - Canada 2.361
HK - Hong Kong 1.982
DK - Danimarca 1.583
SE - Svezia 1.024
IE - Irlanda 728
FR - Francia 699
FI - Finlandia 661
PL - Polonia 641
IN - India 550
AR - Argentina 549
MX - Messico 526
BD - Bangladesh 394
IL - Israele 393
TR - Turchia 358
NL - Olanda 350
ID - Indonesia 338
EC - Ecuador 302
ZA - Sudafrica 281
JP - Giappone 269
ES - Italia 257
IQ - Iraq 197
AT - Austria 182
PK - Pakistan 167
EU - Europa 149
CO - Colombia 146
LT - Lituania 109
PY - Paraguay 108
VE - Venezuela 106
UZ - Uzbekistan 101
MA - Marocco 96
AE - Emirati Arabi Uniti 95
CL - Cile 88
PE - Perù 75
SA - Arabia Saudita 63
KR - Corea 60
UY - Uruguay 60
IR - Iran 58
KE - Kenya 58
EG - Egitto 53
BE - Belgio 46
SK - Slovacchia (Repubblica Slovacca) 46
TN - Tunisia 44
BO - Bolivia 35
CH - Svizzera 35
DZ - Algeria 35
JO - Giordania 35
AZ - Azerbaigian 31
RO - Romania 31
DO - Repubblica Dominicana 30
AU - Australia 29
CZ - Repubblica Ceca 28
NP - Nepal 27
HN - Honduras 24
CR - Costa Rica 23
KZ - Kazakistan 22
JM - Giamaica 21
MY - Malesia 20
PH - Filippine 20
PT - Portogallo 19
AL - Albania 18
AM - Armenia 18
NZ - Nuova Zelanda 18
TW - Taiwan 17
CI - Costa d'Avorio 16
ET - Etiopia 15
OM - Oman 15
TH - Thailandia 15
TT - Trinidad e Tobago 15
GE - Georgia 14
KG - Kirghizistan 14
KW - Kuwait 14
NI - Nicaragua 14
SN - Senegal 14
LB - Libano 13
PA - Panama 13
PS - Palestinian Territory 12
GT - Guatemala 11
BG - Bulgaria 10
BH - Bahrain 10
BY - Bielorussia 10
GR - Grecia 10
GY - Guiana 10
NG - Nigeria 10
RS - Serbia 10
BB - Barbados 9
HU - Ungheria 9
MD - Moldavia 9
LV - Lettonia 8
MC - Monaco 8
GD - Grenada 7
Totale 136.699
Salva come PNG Salva come JPEG
Città #
Dallas 13.815
Singapore 6.248
Southend 5.518
Beijing 3.412
Ashburn 3.236
Woodbridge 2.868
Chandler 2.554
Ann Arbor 2.547
Houston 2.334
Moscow 1.993
Fairfield 1.913
San Mateo 1.857
Los Angeles 1.826
Chicago 1.780
Hong Kong 1.750
Falls Church 1.553
Dearborn 1.327
Seattle 1.324
Jacksonville 1.195
Wilmington 1.148
Cambridge 1.147
Ho Chi Minh City 1.138
Ottawa 943
The Dalles 818
Hefei 803
Salt Lake City 752
Boardman 732
Dublin 710
New York 702
São Paulo 694
Stevenage 685
Buffalo 682
Portsmouth 682
Dong Ket 641
Pisa 622
Hanoi 610
Warsaw 594
Lawrence 525
Santa Clara 450
Beauharnois 444
Brooklyn 429
Tampa 421
Munich 411
Montréal 406
Milan 387
Tel Aviv 351
Elk Grove Village 344
Rome 332
London 321
Montreal 262
Tokyo 241
Rio de Janeiro 223
Denver 217
Poplar 213
San Diego 213
Stockholm 212
Frankfurt am Main 207
Florence 205
Chennai 204
Orem 203
Johannesburg 196
Istanbul 189
Phoenix 187
Mexico City 181
Atlanta 179
Nuremberg 167
Sterling 163
Redwood City 160
Old Bridge 158
Boston 153
Lancaster 153
Belo Horizonte 133
Helsinki 132
Brasília 129
Haiphong 129
Toronto 128
Miami 126
Amsterdam 122
San Francisco 118
Guangzhou 117
Lappeenranta 115
Central District 114
Turku 113
Curitiba 110
Guayaquil 107
Da Nang 105
Manchester 104
Ankara 99
Porto Alegre 99
Dulles 98
Council Bluffs 97
Tashkent 95
Biên Hòa 93
Campinas 91
Fremont 91
Washington 89
Kansas City 86
Querétaro 86
Norwalk 85
Quito 84
Totale 85.355
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.794
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.600
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.511
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.280
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 830
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 662
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 551
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 453
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 444
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 425
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 413
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 407
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 361
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 349
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 345
Cartella clinica automatizzata per il reparto di cardiologia 336
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 332
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 332
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 330
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 328
An Open System for Managing Long Term ECG Recordings 316
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 315
La neuropatia diabetica 314
Building medical knowledge from real world registries: The case of heart failure 314
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 313
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 312
A simple echocardiographic score to rule out cardiac amyloidosis 307
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 305
Central sleep apnea and cardiovascular disease state-of-the-art 302
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 298
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 296
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 295
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 294
Treating chemoreflex in heart failure: modulation or demolition? 293
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 290
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 290
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 289
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 288
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 287
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 285
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 282
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 281
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 281
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 281
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 281
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 280
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 280
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 280
Adrenergic activation in heart failure: blockade or rebalance? 276
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 276
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 274
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 272
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 272
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 269
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 269
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 268
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 268
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 265
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 264
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 264
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 262
Prediction of the chemoreflex gain by common clinical variables in heart failure 262
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 261
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 261
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 259
A simple echocardiographic score to rule out cardiac amyloidosis 258
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 258
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 257
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 256
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 255
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 255
Effects of smoking in patients treated with cardiac resynchronization therapy 254
[Central apneas and cardiovascular diseases] 253
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 253
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 253
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 253
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 252
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 251
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 249
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 249
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 248
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 247
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 247
Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis 246
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 245
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy 245
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 244
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 243
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 243
Development of an Electronic Medical Record for Patient Care in Cardiology 243
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 241
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 240
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 240
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 239
Medical record System for Cardiology and Cardiac Surgery 237
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 237
Totale 34.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 727.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 727.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.529 0 0 0 0 0 1.601 1.075 605 923 664 1.040 1.621
2021/20228.856 788 1.557 404 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.921 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.835 6.773 3.958
2025/202650.807 4.297 13.612 10.203 10.763 8.532 3.400 0 0 0 0 0 0
Totale 137.773